Stocktoria
CVRx, Inc. CVRX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-06-30
CVRx, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 85.3% | 83.8% | 84.1% | 77.8% | 72.1% |
| Operating margin | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% |
| Net margin | -94.1% | -116.9% | -104.8% | -184.4% | -330.5% |
| FCF margin | -71.9% | -79.0% | -100.8% | -193.0% | -221.8% |
| Return on assets | -50.9% | -44.9% | -35.8% | -33.2% | -28.2% |
| Return on equity | -135.6% | -84.4% | -54.2% | -37.9% | -29.5% |
| Debt / equity | 1.26× | 0.69× | 0.38× | 0.06× | 0.00× |
| Current ratio | 7.63 | 12.06 | 14.25 | 15.19 | 25.57 |
| Revenue growth | 10.4% | 30.5% | 74.9% | 72.4% | 115.4% |
Source: SEC EDGAR filings · CIK 0001235912 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.